BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35647897)

  • 21. Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study.
    Herraiz I; Simón E; Gómez-Arriaga PI; Quezada MS; García-Burguillo A; López-Jiménez EA; Galindo A
    Pregnancy Hypertens; 2018 Jul; 13():279-285. PubMed ID: 30177066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Doppler ultrasound at time of diagnosis of late-onset fetal growth restriction in predicting adverse perinatal outcome: prospective cohort study.
    Rizzo G; Mappa I; Bitsadze V; Słodki M; Khizroeva J; Makatsariya A; D'Antonio F
    Ultrasound Obstet Gynecol; 2020 Jun; 55(6):793-798. PubMed ID: 31343783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placental volume at 11 to 14 gestational weeks in pregnancies complicated with fetal growth restriction and preeclampsia.
    Papastefanou I; Chrelias C; Siristatidis C; Kappou D; Eleftheriades M; Kassanos D
    Prenat Diagn; 2018 Nov; 38(12):928-935. PubMed ID: 30188581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placental elasticity evaluation using virtual touch tissue quantification during pregnancy.
    Ohmaru T; Fujita Y; Sugitani M; Shimokawa M; Fukushima K; Kato K
    Placenta; 2015 Aug; 36(8):915-20. PubMed ID: 26149518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of shear wave elastography in predicting preeclampsia in the first trimester.
    Sirinoglu HA; Uysal G; Nazik H; Cingillioglu B; Genc S; Pekin O
    Rev Assoc Med Bras (1992); 2021 Nov; 67(11):1558-1563. PubMed ID: 34909878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction.
    Odibo AO; Zhong Y; Longtine M; Tuuli M; Odibo L; Cahill AG; Macones GA; Nelson DM
    Placenta; 2011 Apr; 32(4):333-8. PubMed ID: 21324404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic utility of serial circulating placental growth factor levels and uterine artery Doppler waveforms in diagnosing underlying placental diseases in pregnancies at high risk of placental dysfunction.
    Agrawal S; Parks WT; Zeng HD; Ravichandran A; Ashwal E; Windrim RC; Hobson SR; Melamed N; Kingdom JC
    Am J Obstet Gynecol; 2022 Oct; 227(4):618.e1-618.e16. PubMed ID: 35644246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia.
    Reddy M; Palmer K; Rolnik DL; Wallace EM; Mol BW; Da Silva Costa F
    Ultrasound Obstet Gynecol; 2022 May; 59(5):596-605. PubMed ID: 34985800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary placental growth factor in preeclampsia and fetal growth restriction: An alternative to circulating biomarkers?
    Zhang K; Zen M; Popovic NL; Lee VW; Alahakoon TI
    J Obstet Gynaecol Res; 2019 Sep; 45(9):1828-1836. PubMed ID: 31257726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction.
    Yu N; Cui H; Chen X; Chang Y
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):358-361. PubMed ID: 28600048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of Kryptor and Elecsys® immunoassay sFlt-1/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: A case-control study.
    Simón E; Herraiz I; Villalaín C; Gómez-Arriaga PI; Quezada MS; López-Jiménez EA; Galindo A
    Pregnancy Hypertens; 2020 Apr; 20():44-49. PubMed ID: 32172169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Corpus Callosum Development With Fetal Growth Restriction and Maternal Preeclampsia or Gestational Hypertension.
    Zheng W; Zhang X; Feng Y; Liu B; Zhu J; Zou Y; Qin J; Li B
    JAMA Netw Open; 2022 Aug; 5(8):e2226696. PubMed ID: 35969398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. sFlt-1/PlGF Ratio at 24 Weeks Gestation in Twin Pregnancies as a Predictor of Preeclampsia or Fetal Growth Restriction.
    Martínez-Varea A; Martínez-Sáez C; Domenech J; Desco-Blay J; Monfort-Pitarch S; Hueso M; Diago-Almela V
    Fetal Diagn Ther; 2022; 49(4):206-214. PubMed ID: 35609518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Placental apoptosis and adhesion molecules expression in the placenta and the maternal placental bed of pregnancies complicated by fetal growth restriction with and without pre-eclampsia.
    Madazli R; Benian A; Ilvan S; Calay Z
    J Obstet Gynaecol; 2006 Jan; 26(1):5-10. PubMed ID: 16390700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of placental neuropilin-1 in fetal growth restriction.
    Maulik D; De A; Ragolia L; Evans J; Grigoryev D; Lankachandra K; Mundy D; Muscat J; Gerkovich MM; Ye SQ
    Am J Obstet Gynecol; 2016 Feb; 214(2):279.e1-279.e9. PubMed ID: 26409917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Placental elastography in a murine intrauterine growth restriction model.
    Quibel T; Deloison B; Chammings F; Chalouhi GE; Siauve N; Alison M; Bessières B; Gennisson JL; Clément O; Salomon LJ
    Prenat Diagn; 2015 Nov; 35(11):1106-11. PubMed ID: 26193351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.
    Garcia-Manau P; Mendoza M; Bonacina E; Garrido-Gimenez C; Fernandez-Oliva A; Zanini J; Catalan M; Tur H; Serrano B; Carreras E
    Acta Obstet Gynecol Scand; 2021 Jan; 100(1):119-128. PubMed ID: 32860218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heme oxygenase expression in human placenta and placental bed: reduced expression of placenta endothelial HO-2 in preeclampsia and fetal growth restriction.
    Barber A; Robson SC; Myatt L; Bulmer JN; Lyall F
    FASEB J; 2001 May; 15(7):1158-68. PubMed ID: 11344084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathologic placental lesions in early and late fetal growth restriction.
    Spinillo A; Gardella B; Adamo L; Muscettola G; Fiandrino G; Cesari S
    Acta Obstet Gynecol Scand; 2019 Dec; 98(12):1585-1594. PubMed ID: 31370094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.